3-(Aminocarbonyl)-1-(5-O-phosphonato-beta-D-ribofuranosyl)pyridinium

146licensed products
1 monograph
Capsule, Capsule, hard, Powder for solution +2

Health Canada Monographs

1

Approved Health Claims

15
  • Source of (an) antioxidant(s)/Provides (an) antioxidant(s) 2
  • Source of (an) antioxidant(s)/Provides (an) antioxidant(s) that help(s) fight/protect (cell) against/reduce (the oxidative effect of/the oxidative damage caused by/cell damage caused by) free radicals 2
  • A factor in the maintenance of good health
  • A factor in normal growth and development
  • Supports biological functions which play a key role in the maintenance of good health
  • Helps normal growth and development
  • Helps in energy metabolism/(and) tissue formation
  • Helps (to) maintain/support the body's ability to metabolize nutrients 3
  • NMN is a NAD+ precursor which is a factor in normal growth and development
  • NMN is a NAD+ precursor which helps to support biological functions which play a key role in the maintenance of good health
  • NMN is a NAD+ precursor which is an important cofactor in energy metabolism
  • 1 NMN is a vitamin B3 derivative and therefore uses associated with vitamin B3 as per the Multi-vitamin/mineral Supplements Monograph are acceptable
  • 2 If NMN is combined with other medicinal ingredients with antioxidant properties, there is an option to use the antioxidant claims in plural. The singular should be used when the product only contains one chemical substance (e.g., NMN) as the medicinal ingredient associated with the antioxidant claim
  • 3 This claim is not intended to convey that taking these vitamins helps to boost metabolism, upregulate a bodily system and/or directly convert food to energy. Inferring such claims would be misleading and is not permitted. In order to avoid any misinterpretation of this claim, the terms 'carbohydrates, fats, proteins, etc.' must not be used to further specify the term 'nutrients'
  • The above uses can be combined on the product label (e.g., Source of an antioxidant and helps normal growth and development)

Approved Dose Ranges

1
PopulationDose RangeFrequency
Adults 18 years and older3–1200 milligramsper day

Cautions & Contraindications

2
cautionAsk a healthcare practitioner/health care provider/health care professional/doctor/physician before use if you are pregnant or breastfeeding.
cautionAsk a healthcare practitioner/health care provider/health care professional/doctor/physician before use if you have diabetes (Yoshino et al. 2021).

Alternative Names

3
NMN(common)Nicotinamide mononucleotide(common)3-(Aminocarbonyl)-1-(5-O-phosphonato-beta-D-ribofuranosyl)pyridinium

Common Quantities in Licensed Products

10
250 mg50 licensed products
300 mg40 licensed products
500 mg37 licensed products
200 mg23 licensed products
150 mg17 licensed products
600 mg16 licensed products
125 mg5 licensed products
350 mg4 licensed products
37.5 mg2 licensed products
100 mg2 licensed products

Check your 3-(Aminocarbonyl)-1-(5-O-phosphonato-beta-D-ribofuranosyl)pyridinium product's compliance

Validate your formulation against Health Canada monographs and 146 licensed products containing 3-(Aminocarbonyl)-1-(5-O-phosphonato-beta-D-ribofuranosyl)pyridinium.

Scan Your Product Free